Serum osteocalcin (bone gla-protein) and bone mineral content in non-insulin dependent diabetes

Carlomaurizio Montecucco(University of Pavia), P. Fratino(Fondazione Salvatore Maugeri), Fabio Baldi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Anna Belloni Fortina(University of Padua), Roberto Caporali(University of Milan), G. Tomassini(Ospedale Maggiore), M Caprotti(University of Pavia)

Unknown

January 1, 1990

Cited by 10

Related Papers

Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study

|Journal of Investigative Dermatology|2005|644

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

|The Lancet|2021|315

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

|Nature Medicine|2022|277

Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects

|Journal of Internal Medicine|2002|252

Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients

|Journal of the European Academy of Dermatology and Venereology|2020|248